These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35611731)

  • 41. Expression of the VP1 protein of FMDV integrated chromosomally with mutant Listeria monocytogenes strain induced both humoral and cellular immune responses.
    Mahdy SE; Liu S; Su L; Zhang X; Chen H; Pei X; Wang C
    Appl Microbiol Biotechnol; 2019 Feb; 103(4):1919-1929. PubMed ID: 30627793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine.
    Alejo DM; Moraes MP; Liao X; Dias CC; Tulman ER; Diaz-San Segundo F; Rood D; Grubman MJ; Silbart LK
    Vaccine; 2013 Apr; 31(18):2302-9. PubMed ID: 23499593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    Gullberg M; Lohse L; Bøtner A; McInerney GM; Burman A; Jackson T; Polacek C; Belsham GJ
    PLoS One; 2016; 11(6):e0157435. PubMed ID: 27294397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins.
    Sanz-Parra A; V Zquez B; Sobrino F; Cox SJ; Ley V; Salt JS
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():671-679. PubMed ID: 10092007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
    Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
    J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus.
    Fan H; Tong T; Chen H; Guo A
    Virus Genes; 2007 Oct; 35(2):347-57. PubMed ID: 17497212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A recombinant adenovirus bicistronically expressing porcine interferon-α and interferon-γ enhances antiviral effects against foot-and-mouth disease virus.
    Kim SM; Kim SK; Park JH; Lee KN; Ko YJ; Lee HS; Seo MG; Shin YK; Kim B
    Antiviral Res; 2014 Apr; 104():52-8. PubMed ID: 24485895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant adenovirus expression of FMDV P1-2A and 3C protein and its immune response in mice.
    Guo C; Zhang C; Zheng H; Huang Y
    Res Vet Sci; 2013 Oct; 95(2):736-41. PubMed ID: 23722010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
    Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
    J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antigenicity and Immunogenicity Analysis of the
    Li G; Wubshet AK; Ding Y; Li Q; Dai J; Wang Y; Hou Q; Chen J; Ma B; Szczotka-Bochniarz A; Szathmary S; Zhang Y; Zhang J
    Viruses; 2021 May; 13(6):. PubMed ID: 34072100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing.
    Brake DA; McIlhaney M; Miller T; Christianson K; Keene A; Lohnas G; Purcell C; Neilan J; Schutta C; Barrera J; Burrage T; Brough DE; Butman BT
    Dev Biol (Basel); 2012; 134():123-33. PubMed ID: 22888605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor.
    Du Y; Jiang P; Li Y; He H; Jiang W; Wang X; Hong W
    Vaccine; 2007 Nov; 25(49):8209-19. PubMed ID: 17980939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
    De Vleeschauwer AR; Zhou X; Lefebvre DJ; Garnier A; Watier F; Pignon C; Lacour SA; Zientara S; Bakkali-Kassimi L; De Clercq K; Klonjkowski B
    Vaccine; 2018 Apr; 36(16):2193-2198. PubMed ID: 29544690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
    Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adenovirus-Vectored Capsid Proteins of the Serotype A Foot-and-Mouth Disease Virus Protect Guinea Pigs Against Challenge.
    Xie Y; Chang H; Li Z; Zhang Y
    Front Microbiol; 2020; 11():1449. PubMed ID: 32733405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).
    Xu H; Bao X; Lu Y; Liu Y; Deng B; Wang Y; Xu Y; Hou J
    Vet Microbiol; 2017 Jun; 205():46-52. PubMed ID: 28622860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
    You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
    Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Engineering better vaccines for foot-and-mouth disease.
    Mason PW; Chinsangaram J; Moraes MP; Mayr GA; Grubman MJ
    Dev Biol (Basel); 2003; 114():79-88. PubMed ID: 14677679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of an Indirect Chemiluminescence Immunoassay Using a Multiepitope Recombinant Protein To Specifically Detect Antibodies against Foot-and-Mouth Disease Virus Serotype O in Swine.
    Liu W; Shao J; Zhang G; Chang Y; Ge S; Sun Y; Gao Z; Chang H
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33328177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.